The document contains 5 tables that describe diseases associated with monoclonal immunoglobulins, plasma cell neoplasms, the chemical structure of immune modulator drugs, features that distinguish benign and malignant paraproteinemia, and the classification of amyloidosis by type, structure, and organ involvement. Table 1 lists neoplastic and benign diseases associated with monoclonal immunoglobulins. Table 2 describes plasma cell neoplasms according to the WHO classification. Table 3 shows the chemical structures of thalidomide, lenalidomide, and pomalidomide and their common side effects. Table 4 outlines features that can differentiate between benign and malignant paraproteinemia. Table 5 classifies types of amyloidosis by their chemical nature and the organs